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Abstract. With widespread use of microarray technology as a poten-
tial diagnostics tool, the comparison of results obtained from the use of
diﬀerent platforms is of interest. When inference methods are designed
using data collected using a particular platform, they are unlikely to
work directly on measurements taken from a diﬀerent type of array. We
report on this cross-platform transfer problem, and show that working
with transcriptome representations at binary numerical precision, similar
to the gene expression bar code method, helps circumvent the variability
across platforms in several cancer classiﬁcation tasks. We compare our
approach with a recent machine learning method speciﬁcally designed for
shifting distributions, i.e., problems in which the training and testing
data are not drawn from identical probability distributions, and show
superior performance in three of the four problems in which we could
directly compare.
Keywords: Cross-platform analysis, binary gene expression,
classiﬁcation.
1 Introduction
The ability to observe the expression levels, or relative mRNA abundances, of
thousands of genes in a given biological sample makes microarray technology
a widely used tool in experimental biology. The potential of the technology
as a diagnostic tool, producing a high dimensional feature vector upon which
statistical pattern classiﬁcation techniques such as Support Vector Machines
(SVM) can be trained and applied, has received signiﬁcant attention over the
last decade [1]. Datasets from complex diseases including diﬀerent types of cancer
and diabetes have been analyzed in this manner, subsets of genes that are useful
in discriminating the population with a disease from normal population have
been identiﬁed for further validation.
A particular issue in such studies is variability at the biological and technical
levels. Reproducibility of microarray results across diﬀerent biological samples
taken from the same tissue is reported to be very poor [2], while reproducibility
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across technical replicates of ampliﬁed isolated mRNA is generally good [3].
Reasons for this have to do with the fact that mRNA is taken from a population
of cells, each of which carrying a very small number of copies of each species.
Except in experimental settings where the cells are artiﬁcially synchronized,
this observation is largely true, leading to large biological variability. Similarly,
variations in results across diﬀerent laboratories and across platforms have been
noted [4,5]. Much researchin microarraystudies is aimed at developing analytical
techniques that are robust to systematic measurement variations.
In our past work [6], motivated by the observation that high numerical preci-
sion with which gene expression levels are reported in archives is incompatible
with large biological variability, we showed that the quality of inference drawn
from microarray studies is often not aﬀected by progressive quantization of the
expression levels. We established this in a number of diﬀerent inference problems:
classiﬁcation, cluster analysis, detection of periodically expressed genes and the
analysis of developmental time-course data. Building on this, we further showed
that with a binary representation of the transcriptome, i.e., retaining only the
information whether a gene is expressed or not, one could often achieve superior
results by proper choice of distance metrics. Speciﬁcally, we used the Tanimoto
similarity [7], borrowed from the chemoinformatics literature, and were able to
explain some of the improvements obtained by a systematic variation in the
probe level uncertainties of Aﬀymetrix gene arrays [8]. We also established that
in such reduced numerical precision representations, variability of inference aris-
ing from algorithmic choice in the pipeline of various pre-processing stages can
be signiﬁcantly reduced.
Binary representation of transcriptome has been shown to be eﬀective in deal-
ing with variation between laboratories by Zilliox and Irizzary [9], in their bar
code method. The bar code is simply a binary representation of microarray out-
puts, but is computed over a very large collection of hybridizations of a particular
type of array. In [9], the authors studied Aﬀymetrix HGU133A Human array and
using their barcodes and a simple nearest distance to template classiﬁer demon-
strated impressive results of tissue speciﬁcity of cancer populations. A particu-
lar limitation of the approach is distance-to-template classiﬁcation, because it
is known in statistical pattern recognition that such a classiﬁer is optimal only
for equal variance isotropic class conditional densities [10]. For gene expression
data, this is a poor assumption because genes regulated by common transcrip-
tion factors and those acting on signal transduction common pathways are often
co-expressed. Complex diseases are often realized as disruptions in pathways or
regulation, thus correlated expression should be very common in such datasets.
While on the data used in [9] good results are obtained, it is not too diﬃcult to
ﬁnd counter examples in which the performance of the bar code method is poor
(see section 2.3). Similarly, Shmulevich and Zhang [11] also note the advantage
of working with binary transcriptome data.
Warnat et al. [12] and Gretton et al. [13] oﬀer novel algorithmic approaches
for dealing with cross-platform variations. In their formulation training data for
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microarray platform and the unseen test data is assumed to come from a dif-
ferent platform. As one would expect, with no adjustment to the data, test set
performance is very poor. In [12], Warnat et al. oﬀer two solutions to improving
on this: the use of median rank scores and quantile discretizations. The former
approach uses ranks of genes as features in computing similarity metrics while
the latter quantizes data into eight bins, the ranges of which are set to equalize
bin occupancy. The second method is similar in spirit to the method we advocate
in that ours is to quantize down to binary levels. In [13], Gretton et al. develop
an approach aimed at the more generic problem of test set distributions being
diﬀerent from training set distributions. A weighting scheme known as kernel
mean matching (KMM) is developed and microarray cross-platform inference is
used as a test problem to evaluate their algorithm.
Binarizing continuous valued data as a means of improving the performance
of speciﬁc classiﬁers have been reported in the machine learning literature in the
past [14]. Such work, however, is not generic and is merely a statement about ac-
cidental improvements over weak baseline classiﬁers (naive Bayes, decision trees
etc.). Our results are speciﬁc to transcriptome data and build on observed prop-
erties of the measurement environment. Further, our comparisons are against
classiﬁer with high performance (i.e., SVM).
In this paper we show that a binary representation of the transcriptome, when
combined with a suitable similarity metric and cast in a kernel classiﬁer setting,
can yield performance that is competitive, and often superior, to methods de-
veloped in the literature to address this problem. This, and other examples of
high performance from binary representations we have reported previously, arise
largely from the fact that often the useful information relating to gene expression
is simply if it is transcribed or not, rather than in the actual cellular concen-
tration of the transcripts. Even if the information is in transcript abundances,
as noted earlier, heterogeneity within a population of cells makes the measure-
ment unreliable. In this context, quantization of the data has a noise rejection
property which our method takes advantage of.
2 Methods
2.1 Quantization
Quantization of microarray has been studied in the literature, for example
[15,16,17]. Among possible methods, we choose the quantization method of Zhou
et al. [15] where mixture of Gaussians are used for the diﬀerent states of gene ex-
pression values. Our justiﬁcation for choosing [15]’s method is that it is relatively
more principled than other approaches for quantization. Arbitrary thresholds set
by other researchers are not necessarily transferable across diﬀerent platforms
or experiments due to variabilities induced by image processing and normaliza-
tion, while the method in [15] depends on the underlying probability density
of the expression levels and hence the idea is portable to any situation. We fo-
cused on binary representation of these measurements. Gene expression values
are quantized by ﬁtting Gaussian mixture model to the expression values:442 S. Tuna and M. Niranjan
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Fig.1. Histogram of expression levels taken from [25] and a two component Gaussian
mixture model of the distribution. The quantization threshold is a function of the
means and standard deviations of the two mixture components (Eqn. 2).
p(x)=
M 
k=1
λk N(μk, σk)( 1 )
where p(x) is the probability density of gene expression measurement, M,t h e
number of mixture components, and N(μ,σ) is a Gaussian density of mean μ
and standard deviation σ. Fitting such a model is by standard maximum like-
lihood techniques, and we used the gmm function in NETLAB software (http://
www.ncrg.aston.ac.uk) for this purpose. We used two component mixtures,
corresponding to M = 2 in the above equation. Fig. 1 shows an example of gene
expression values ﬁtted to two center GMM.
After learning parameters of the model, threshold This chosen as:
Th=
μ1 + σ1 + μ2 − σ2
2
(2)
to achieve binary quantization.
2.2 Tanimoto Kernel
Tanimoto coeﬃcient (T) [7], between two binary vectors of gene expressions, is
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T =
c
a + b − c
(3)
where a is the number of expressed points for the ﬁrst gene, b is the number of
expressed points for the second gene and c is the number of common expressed
points in two genes. Tanimoto similarity ranges from 0 (no points in common)
to 1 (exact match) and is the rate of the number of common bits on to the total
number of bits on two vectors. It focuses on the number of common bits that
are on.
Following the deﬁnition of Tanimoto similarity, Tanimoto kernel is deﬁned as
[18,19]:
KTan(x,z)=
xTz
xTx + zTz − xTz
(4)
where a = xTx, b = zTz and c = xTz. It follows from the work of Swamidass
et al. [18] and Trotter [19] that this similarity metric is useful as a valid kernel,
i.e., kernel computations in the space of the given binary vectors map onto inner
products in a higher dimensional space so that SVM type optimizations for large
margin class boundaries is possible. We incorporated this kernel into the MATLAB
SVM implementation of Steve Gunn [20] (http://www.isis.ecs.soton.ac.
uk/isystems/kernel/).
2.3 Bar Code vs. SVM
Since the bar code method of Zilliox and Irizarry [9] is the closest in literature
to our work, we give a quick overview and evaluation of its performance. The
binary representation for a class of data (tumor in a particular tissue) is de-
rived for a particular array, Aﬀymetrix HGU133A Human array, by scanning
through a large collection of expression levels archived in microarray reposito-
ries. Predictions on test data are made by computing nearest Euclidean distance
to pre-computed bar codes. As we note in the introduction, we should be skep-
tical about high performance from a distance-to-template classiﬁer as such an
approach is only Bayes’ optimal under isotropic equal variance assumptions. To
verify this, we ﬁrst established that the bar code approach cannot compete with
SVM. We used the R code which is made available by the authors’ at their web
page: http://rafalab.jhsph.edu/barcode/ and used three datasets down-
loaded from ArrayExpress (http://www.ebi.ac.uk/arrayexpress/) and Gene
Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/). Two of
these were used in [9] and the other was not. Prediction accuracies for these
three, comparing the bar code method to Tanimoto-SVM, are shown in Table
1. We note that training and testing on the same database, as we have done
with Tanimoto-SVM, achieves consistently better prediction accuracies than the
bar code method. But in fairness to the bar code method we remark that their
intention is to make predictions on a new dataset based on accumulated his-
toric knowledge, rather than repeat the training/testing process all over again.
On this point, while there is impressive performance reported on the datasets444 S. Tuna and M. Niranjan
Table 1. Comparison of Tanimoto-SVM with [9]’ s bar code
Dataset Data type Method Accuracy
E-GEOD-10072 Binary Bar code 0.50
Lung Binary Tanimoto-SVM 0.89 ± 0.03
Lung tumor vs. normal Binary Tanimoto-SVM 0.99 ± 0.03
GSE2665 Binary Bar code 0.95
lymph node/tonsil Binary Tanimoto-SVM 0.99 ± 0.02
lymph node vs. tonsil Binary Tanimoto-SVM 1.0 ± 0.0
GSE2603 Binary Bar code 0.90
Breast Tumor Binary Tanimoto-SVM 0.99 ± 0.01
Breast Tumor vs. normal Binary Tanimoto-SVM 0.99 ± 0.01
Zilliox and Irizarry [9] worked on, the method can fail badly too, as in the case
of the lung cancer prediction task E-GEOD-10072 shown in Table 1. On Table 1
‘Lung’ corresponds to classifying lung vs. breast and lymph node/tonsil which is
a similar approach to bar code. ‘lung tumor vs. normal’ corresponds classifying
tumor vs. normal in lung only. The same terminology applies to the other two
problems as well.
Part of the success of the Tanimoto kernel in the microarray setting comes
from a systematic variability at the probe level of Aﬀymetrix arrays. We have
noted [8] that in a given experiment, the average probe level uncertainty com-
puted amongst expressed genes systematically reduces with the number of ex-
pressed genes; i.e., the larger the number of expressed genes lower the uncertainty
of measurements. Amongst 50 experiments we looked at there was only one ex-
periment for which this observation did not hold. This variability has a direct
bearing when using Tanimoto similarity. For two pairs of expression proﬁles
which diﬀer by the same Hamming (or Euclidean) distance, Tanimoto similarity
will be higher for the pair that has a greater number of expressed genes (thereby
placing a higher emphasis on experiments with lower probe level uncertainties).
Other authors have also exploited probe level uncertainties in principal compo-
nent analysis [22,23] and cluster analysis [24].
3 Experiments
3.1 Datasets
To demonstrate how binary representations help in cross-platform inference, we
carried out experiments on breast and prostate cancer datasets. These datasets
are the same as those used in [12] and [13] and were given to us by the authors
in processed format (i.e., we worked with the expression levels rather than with
the raw data at the CEL ﬁle or image levels). These data come from spotted
cDNA and Aﬀymetrix platforms, and details of the four datasets are summarized
in Tables 2 and 3. Warnat et al. [12] preprocessed all the data and found theCross-Platform Analysis with Binarized Gene Expression Data 445
Table 2. Details of breast cancer studies
Study
Breast cancer
Platform No of common genes Samples Target variable
West et al. [25] Aﬀymetrix 2166 49 ER-status: 25(+), 24(-)
Gruvberger et al. [26] cDNA 2166 58 ER-status: 28(+), 30(-)
Table 3. Details of prostate cancer studies
Study
Prostate cancer
Platform No of common genes Samples Target variable
Welsh et al. [27] Aﬀymetrix 4344 33 9 normal, 24 tumor
Dhanasekaran et al. [28] cDNA 4344 53 19 normal, 34 tumor
subset of common genes by means of the Unigene database (http://www.ncbi.
nlm.nih.gov/unigene).
3.2 SVM Classiﬁcation
InimplementingSVMclassiﬁers,weﬁrstensuredthatourimplementationachieves
the same results as reported in [12]. Table 6, “cont-not normalized” column con-
ﬁrmsthatourimplementationachievesthesameresultsreportedpreviously.Then,
following the suggestion in [13], we normalized each array to have a mean of zero
and standard deviation one, and trained and tested our SVM implementations.
This normalization has a signiﬁcant impact on the results (“cont-normalized”, in
Table 6). As used in these papers we used linear kernel SVMs with a setting of
C = 1000 for the margin parameter, and conﬁrmed previously quoted results are
reproducible.WethenquantizedthedataandappliedTanimotokernelSVM.Note
thatthis kernelhasno tuning parameters.We implementedquantizationonanar-
ray by array basis. In previous work we have experimented with diﬀerent ways of
quantization (array by array, gene by gene and a global method), and noted only
small diﬀerences between these over a range of quantization thresholds [6].
3.3 Results
Tables 4 and 5 show the diﬀerence in classiﬁcation between continuous and
binary representations on the two cancer classiﬁcation problems. Accuracies are
shown for 25 random partitions of the data into training and testing sets, along
with standard deviations quantifying the uncertainty in this process. We see
that in three out of the four cases, binarization, and the use of Tanimoto kernel,
oﬀers signiﬁcant improvements, and performs no worse than continuous data in
the fourth. In Warnat et al. [12], results are averaged over 10 cross validation
runs, but the paper does not report the variation across results.
Table 6 presents results of training SVMs with one type of data and test-
ing the performance on data from a diﬀerent platform. In this cross-platform446 S. Tuna and M. Niranjan
Table 4. Breast cancer results for cross-platform analysis. Data is randomly partitioned
into training and testing for 25 times.
Dataset Data type Method Accuracy
Gruvberger et al. Cont. Linear-SVM 0.80±0.07
Gruvberger et al. Binary Tanimoto-SVM 0.82±0.08
West et al. Cont. Linear-SVM 0.76±0.15
West et al. Binary Tanimoto-SVM 0.79±0.11
Table 5. Prostate cancer results for cross-platform analysis. Data is randomly parti-
tioned into training and testing for 25 times.
Dataset Data type Method Accuracy
Dhanasekaran et al. Cont. Linear-SVM 0.89 ± 0.06
Dhanasekaran et al. Binary Tanimoto-SVM 0.89 ± 0.05
Welsh et al. Cont. Linear-SVM 0.92 ± 0.06
Welsh et al. Binary Tanimoto-SVM 0.96 ± 0.06
Table 6. Cross-platform results. Array-by-array quantization. The notation “Gru-
vberger → West” indicates that we train on Gruvberger’ s data and test on West’ s
data.
Dataset Data type Accuracy
Gruvberger → West Cont.(not normalized) 0.49
Gruvberger → West Cont.(normalized) 0.94
Gruvberger → West Binary 0.96
West → Gruvberger Cont.(not normalized) 0.52
West → Gruvberger Cont.(normalized) 0.93
West → Gruvberger Binary 0.90
Dhanasekaran → Welsh Cont.(not normalized) 0.27
Dhanasekaran → Welsh Cont.(normalized) 1
Dhanasekaran → Welsh Binary 1
Welsh → Dhanasekaran Cont.(not normalized) 0.64
Welsh → Dhanasekaran Cont.(normalized) 0.93
Welsh → Dhanasekaran Binary 1
comparison, normalization as a ﬁrst step has a big impact. Further improve-
ment is obtained by our binarized Tanimoto approach. While in one of the four
experiments this approach gives poor performance, it proves useful in the other
three. In Table 7 we give a comparison with other previously published results
on the same datasets, namely the median rank and quantile discretization of
[12] and the kernel mean matching approach of [13]. While the number of exper-
iments is small, we note that the binarized Tanimoto method we advance has
merit in terms of its performance in a cross-platform setting.Cross-Platform Analysis with Binarized Gene Expression Data 447
Table 7. Comparison of our approach to the published results in literature. Accuracies
obtained by SVM are compared.
Study Train → Test
Method
MRS QD KMM Binary
Breast cancer
Gruvberger → West 0.63 0.86 0.94 0.96
West → Gruvberger 0.95 0.92 0.95 0.90
Prostate cancer
Dhana → Welsh 0.88 0.97 0.91 1
Welsh → Dhana 0.89 0.91 0.83 1
Note KMM is a sample re-weighting process designed to match the test set
distribution to the training set (in feature space means) by a quadratic program-
ming formulations. With microarray data, imposing such a shift is an artiﬁcial
construct, whereas our results show that similar, if not superior, performance is
achievable simply by choosing an appropriate data representation.
4C o n c l u s i o n
In this paper we show that a binary representation of gene expression proﬁles,
combined with a kernel similarity metric that is appropriate for such data, has
the potential to address the important problem in microarray based phenotype
classiﬁcations of cross-platform inference. While the experimental work is on a
very small number of datasets, which were the only ones available to us at this
time from previous studies, we believe this advantage comes from using a data
representation that respects properties of the measurement environment. This
approach is not only limited to cross-platform analysis but can also be success-
fully applied in Aﬀymetrix vs. Aﬀymetrix (e.g. see results in Table 1) where
we show that data from one Aﬀymetrix platform can be robustly transferred to
another. Our current work is on extending the study to a larger collection of
datasets, the diﬃculty in doing this being the matching of the gene identities.
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